Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Paion
About
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
- Aachen,Nordrhein-Westfalen,Germany
- 11 - 50
- http://www.paion.com
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Stock Symbol
- etr:PA8
- Legal Name
- PAION AG
PAION AG, together with its subsidiaries, operates as a biopharmaceutical company that engages in developing and commercializing drug candidates for diseases or interventions with a substantial unmet medical need.The company’s lead compound is remimazolam, an intravenous, ultra-short-acting, and controllable benzodiazepine sedative/anesthetic drug candidate for which PAION has completed the clinical development for use in procedural sedation in the U.S. Outside. The product can be used for general anesthesia in Europe and procedural sedation in the United States.It was founded in 2000 and is based in Aachen, Nordrhein-Westfalen, Germany.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 3, 2018 | Post-IPO Equity | €5.20M | — | — | — | Detail |
| Jul 17, 2017 | Post-IPO Equity | €8M | — | — | — | Detail |
| Jun 29, 2016 | Post-IPO Equity | €9.60M | — | — | — | Detail |
| Jul 30, 2014 | Post-IPO Equity | $6.74M | — | — | — | Detail |
| Feb 18, 2014 | Post-IPO Equity | $4.34M | — | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Reference Capital SA
|
— | Series D |
Employee Profiles
